These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 11107137)

  • 1. Tyrosine hydroxylase-based DNA-vaccination is effective against murine neuroblastoma.
    Lode HN; Pertl U; Xiang R; Gaedicke G; Reisfeld RA
    Med Pediatr Oncol; 2000 Dec; 35(6):641-6. PubMed ID: 11107137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA minigene vaccination for adjuvant neuroblastoma therapy.
    Lode HN; Huebener N; Zeng Y; Fest S; Weixler S; Gaedicke G
    Ann N Y Acad Sci; 2004 Dec; 1028():113-21. PubMed ID: 15650237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccination with minigenes encoding for novel 'self' antigens are effective in DNA-vaccination against neuroblastoma.
    Huebener N; Lange B; Lemmel C; Rammensee HG; Strandsby A; Wenkel J; Jikai J; Zeng Y; Gaedicke G; Lode HN
    Cancer Lett; 2003 Jul; 197(1-2):211-7. PubMed ID: 12880984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A rationally designed tyrosine hydroxylase DNA vaccine induces specific antineuroblastoma immunity.
    Huebener N; Fest S; Strandsby A; Michalsky E; Preissner R; Zeng Y; Gaedicke G; Lode HN
    Mol Cancer Ther; 2008 Jul; 7(7):2241-51. PubMed ID: 18645033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Co-expression of IL-15 enhances anti-neuroblastoma effectivity of a tyrosine hydroxylase-directed DNA vaccination in mice.
    Marx M; Zumpe M; Troschke-Meurer S; Shah D; Lode HN; Siebert N
    PLoS One; 2018; 13(11):e0207320. PubMed ID: 30452438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Xenogeneic immunization with human tyrosine hydroxylase DNA vaccines suppresses growth of established neuroblastoma.
    Huebener N; Fest S; Hilt K; Schramm A; Eggert A; Durmus T; Woehler A; Stermann A; Bleeke M; Baykan B; Weixler S; Gaedicke G; Lode HN
    Mol Cancer Ther; 2009 Aug; 8(8):2392-401. PubMed ID: 19671753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunotherapy with a posttranscriptionally modified DNA vaccine induces complete protection against metastatic neuroblastoma.
    Pertl U; Wodrich H; Ruehlmann JM; Gillies SD; Lode HN; Reisfeld RA
    Blood; 2003 Jan; 101(2):649-54. PubMed ID: 12393580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of GD2 peptide mimotope DNA vaccines effective against spontaneous neuroblastoma metastases.
    Fest S; Huebener N; Weixler S; Bleeke M; Zeng Y; Strandsby A; Volkmer-Engert R; Landgraf C; Gaedicke G; Riemer AB; Michalsky E; Jaeger IS; Preissner R; Förster-Wald E; Jensen-Jarolim E; Lode HN
    Cancer Res; 2006 Nov; 66(21):10567-75. PubMed ID: 17079481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IFN-gamma-inducible protein-10 is essential for the generation of a protective tumor-specific CD8 T cell response induced by single-chain IL-12 gene therapy.
    Pertl U; Luster AD; Varki NM; Homann D; Gaedicke G; Reisfeld RA; Lode HN
    J Immunol; 2001 Jun; 166(11):6944-51. PubMed ID: 11359856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survivin minigene DNA vaccination is effective against neuroblastoma.
    Fest S; Huebener N; Bleeke M; Durmus T; Stermann A; Woehler A; Baykan B; Zenclussen AC; Michalsky E; Jaeger IS; Preissner R; Hohn O; Weixler S; Gaedicke G; Lode HN
    Int J Cancer; 2009 Jul; 125(1):104-14. PubMed ID: 19291796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multi-antigen DNA vaccine delivered by polyethylenimine and Salmonella enterica in neuroblastoma mouse model.
    Stegantseva MV; Shinkevich VA; Tumar EM; Meleshko AN
    Cancer Immunol Immunother; 2020 Dec; 69(12):2613-2622. PubMed ID: 32594197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Salmonella SL7207 application is the most effective DNA vaccine delivery method for successful tumor eradication in a murine model for neuroblastoma.
    Berger E; Soldati R; Huebener N; Hohn O; Stermann A; Durmus T; Lobitz S; Zenclussen AC; Christiansen H; Lode HN; Fest S
    Cancer Lett; 2013 May; 331(2):167-73. PubMed ID: 23337288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conjugation of new DNA vaccine with polyethylenimine induces cellular immune response and tumor regression in neuroblastoma mouse model.
    Stegantseva MV; Shinkevich VA; Tumar EM; Meleshko AN
    Exp Oncol; 2020 Jun; 42(2):120-125. PubMed ID: 32602294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transfer of eukaryotic expression plasmids to mammalian hosts by attenuated Salmonella spp.
    Weiss S
    Int J Med Microbiol; 2003 Apr; 293(1):95-106. PubMed ID: 12755370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CpG oligonucleotides enhance the tumor antigen-specific immune response of a granulocyte macrophage colony-stimulating factor-based vaccine strategy in neuroblastoma.
    Sandler AD; Chihara H; Kobayashi G; Zhu X; Miller MA; Scott DL; Krieg AM
    Cancer Res; 2003 Jan; 63(2):394-9. PubMed ID: 12543793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An attenuated Salmonella oral DNA vaccine prevents the growth of hepatocellular carcinoma and colon cancer that express alpha-fetoprotein.
    Chou CK; Hung JY; Liu JC; Chen CT; Hung MC
    Cancer Gene Ther; 2006 Aug; 13(8):746-52. PubMed ID: 16410824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroblastoma directed therapy by a rational prodrug design of etoposide as a substrate for tyrosine hydroxylase.
    Jikai J; Shamis M; Huebener N; Schroeder U; Wrasidlo W; Wenkel J; Lange B; Gaedicke G; Shabat D; Lode HN
    Cancer Lett; 2003 Jul; 197(1-2):219-24. PubMed ID: 12880985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral delivery of DNA vaccines using attenuated Salmonella typhimurium as carrier.
    Darji A; zur Lage S; Garbe AI; Chakraborty T; Weiss S
    FEMS Immunol Med Microbiol; 2000 Apr; 27(4):341-9. PubMed ID: 10727890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroblastoma triggers an immunoevasive program involving galectin-1-dependent modulation of T cell and dendritic cell compartments.
    Soldati R; Berger E; Zenclussen AC; Jorch G; Lode HN; Salatino M; Rabinovich GA; Fest S
    Int J Cancer; 2012 Sep; 131(5):1131-41. PubMed ID: 22020795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A dual-function DNA vaccine encoding carcinoembryonic antigen and CD40 ligand trimer induces T cell-mediated protective immunity against colon cancer in carcinoembryonic antigen-transgenic mice.
    Xiang R; Primus FJ; Ruehlmann JM; Niethammer AG; Silletti S; Lode HN; Dolman CS; Gillies SD; Reisfeld RA
    J Immunol; 2001 Oct; 167(8):4560-5. PubMed ID: 11591784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.